Quantitative tissue and gene-specific differences and developmental changes in Nat1, Nat2, and Nat3 mRNA expression in the rat

Drug Metabolism and Disposition

Volumn 36, Issue 12, 2008, Pages 2445-2451

  Barker, David F ^a   Walraven, Jason M ^a   Ristagno, Elizabeth H ^a   Doll, Mark A ^a   States, J Christopher ^a   Hein, David W ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLTRANSFERASE; AROMATIC AMINE; ARYLAMINE ACETYLTRANSFERASE; N ACETYLTRANSFERASE 1; N ACETYLTRANSFERASE 3; UNCLASSIFIED DRUG;

ACETYLATION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOTRANSFORMATION; BLADDER; COLON; CONTROLLED STUDY; DEVELOPMENTAL STAGE; FEMALE; FISCHER 344 RAT; GENE EXPRESSION; GENETIC POLYMORPHISM; LIVER; LUNG; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEX DIFFERENCE; SPRAGUE DAWLEY RAT; TISSUE SPECIFICITY; XENOBIOTIC METABOLISM;

AGING; ANIMALS; ARYLAMINE N-ACETYLTRANSFERASE; COLON; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENE EXPRESSION REGULATION, ENZYMOLOGIC; ISOENZYMES; LIVER; MALE; ORGAN SPECIFICITY; POLYMERASE CHAIN REACTION; RATS; RATS, INBRED F344; RATS, SPRAGUE-DAWLEY; SEX CHARACTERISTICS;

RATTUS;

EID: 57349163483     PISSN: 00909556     EISSN: 1521009X     Source Type: Journal    
DOI: 10.1124/dmd.108.023564     Document Type: Article

References (25)

1. Boukouvala S and Fakis G (2005) Arylamine N-acetyltransferases: what we learn from genes and genomes. Drug Metab Rev 37:511-564.
2. Boukouvala S, Price N, Plant KE, and Sim E (2003) Structure and transcriptional regulation of the Nat2 gene encoding for the drug-metabolizing enzyme arylamine N-acetyltransferase type 2 in mice. Biochem J 375:593-602.
3. Ebisawa T, Sasaki Y, and Deguchi T (1995) Complementary DNAs for two arylamine N-acetyltransferases with identical 5′ non-coding regions from rat pineal gland. Eur J Biochem 228:129-137.
4. Estrada L, Kanelakis KC, Levy GN, and Weber WW (2000) Tissue- and gender-specific expression of N-acetyltransferase 2 (Nat2*) during development of the outbred mouse strain CD-1. Drug Metab Dispos 28:139-146.
5. Estrada-Rodgers L, Levy GN, and Weber WW (1998) Substrate selectivity of mouse N-acetyltransferases 1, 2, and 3 expressed in COS-1 cells. Drug Metab Dispos 26:502-505.
6. Fretland AJ, Doll MA, Gray K, Feng Y, and Hein DW (1997) Cloning, sequencing, and recombinant expression of NAT1, NAT2, and NAT3 derived from the C3H/HeJ (rapid) and A/HeJ (slow) acetylator inbred mouse: functional characterization of the activation and deactivation of aromatic amine carcinogens. Toxicol Appl Pharmacol 142:360-366.
7. Hanna PE (1994) N-Acetyltransferases, O-acetyltransferases, and N,O-acetyltransferases: enzymology and bioactivation. Adv Pharmacol 27:401-430.
8. Hein DW (1988) Acetylator genotype and arylamine-induced carcinogenesis. Biochim Biophys Acta 948:37-66.
9. Hein DW (2000) N-Acetyltransferase genetics and their role in predisposition to aromatic and heterocyclic amine-induced carcinogenesis. Toxicol Lett 112-113:349-356.
10. Hein DW, Doll MA, Fretland AJ, Gray K, Deitz AC, Feng Y, Jiang W, Rustan TD, Satran SL, and Wilkie TR Sr (1997) Rodent models of the human acetylation polymorphism: comparisons of recombinant acetyltransferases. Mutat Res 376:101-106.
11. Hein DW, Doll MA, Fretland AJ, Leff MA, Webb SJ, Xiao GH, Devanaboyina US, Nangju NA, and Feng Y (2000) Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms. Cancer Epidemiol Biomarkers Prev 9:29-42.
12. Hein DW, Doll MA, Nerland DE, and Fretland AJ (2006) Tissue distribution of N-acetyltransferase 1 and 2 catalyzing the N-acetylation of 4-aminobiphenyl and O-acetylation of N-hydroxy-4-aminobiphenyl in the congenic rapid and slow acetylator Syrian hamster. Mol Carcinog 45:230-238.
13. Hein DW, Rustan TD, Bucher KD, Furman EJ, and Martin WJ (1991a) Extrahepatic expression of the N-acetylation polymorphism toward arylamine carcinogens in tumor target organs of an inbred rat model. J Pharmacol Exp Ther 258:232-236.
14. Hein DW, Rustan TD, Bucher KD, Martin WJ, and Furman EJ (1991b) Acetylator phenotype-dependent and -independent expression of arylamine N-acetyltransferase isozymes in rapid and slow acetylator inbred rat liver. Drug Metab Dispos 19:933-937.
15. Husain A, Zhang X, Doll MA, States JC, Barker DF, and Hein DW (2007a) Functional analysis of the human N-acetyltransferase 1 major promoter: quantitation of tissue expression and identification of critical sequence elements. Drug Metab Dispos 35:1649-1656.
16. Husain A, Zhang X, Doll MA, States JC, Barker DF, and Hein DW (2007b) Identification of N-acetyltransferase 2 (NAT2) transcription start sites and quantitation of NAT2-specific mRNA in human tissues. Drug Metab Dispos 35:721-727.
17. Kawamura A, Westwood I, Wakefield L, Long H, Zhang N, Walters K, Redfield C, and Sim E (2008) Mouse N-acetyltransferase type 2, the homologue of human N-acetyltransferase type 1. Biochem Pharmacol 75:1550-1560.
18. Kelly SL and Sim E (1994) Arylamine N-acetyltransferase in BALB/c mice: identification of a novel mouse isoenzyme by cloning and expression in vitro. Biochem J 302 (Pt 2):347-353.
19. Loehle JA, Cornish V, Wakefield L, Doll MA, Neale JR, Zang Y, Sim E, and Hein DW (2006) N-Acetyltransferase (Nat) 1 and 2 expression in Nat2 knockout mice. J Pharmacol Exp Ther 319:724-728.
20. McQueen CA and Chau B (2003) Neonatal ontogeny of murine arylamine N-acetyltransferases: implications for arylamine genotoxicity. Toxicol Sci 73:279-286.
21. McQueen CA, Mitchell MK, Dang LN, Chau B, Tjalkens RB, and Philbert MA (2003) Prenatal expression of N-acetyltransferases in C57BL/6 mice. Chem Biol Interact 145:77-87.
22. Sugamori KS, Brenneman D, Wong S, Gaedigk A, Yu V, Abramovici H, Rozmahel R, and Grant DM (2007) Effect of arylamine acetyltransferase Nat3 gene knockout on N-acetylation in the mouse. Drug Metab Dispos 35:1064-1070.
23. Sugamori KS, Wong S, Gaedigk A, Yu V, Abramovici H, Rozmahel R, and Grant DM (2003) Generation and functional characterization of arylamine N-acetyltransferase Nat1/Nat2 double-knockout mice. Mol Pharmacol 64:170-179.
24. Walraven JM, Barker DF, Doll MA, and Hein DW (2007) Tissue expression and genomic sequences of rat N-acetyltransferases rNat1, rNat2, rNat3, and functional characterization of a novel rNat3*2 genetic variant. Toxicol Sci 99:413-421.
25. Walraven JM, Doll MA, and Hein DW (2006) Identification and characterization of functional rat arylamine N-acetyltransferase 3: comparisons with rat arylamine N-acetyltransferases 1 and 2. J Pharmacol Exp Ther 319:369-375.